Carteolol

Chemical formula: C₁₆H₂₄N₂O₃  Molecular mass: 292.373 g/mol  PubChem compound: 2583

Therapeutic indications

Carteolol is indicated for:

Ocular hypertension, chronic open angle glaucoma, secondary glaucomas

Population group: only adults (18 years old or older)

For the reduction of intraocular pressure e.g. in ocular hypertension, chronic open angle glaucoma, some secondary glaucomas.

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Contraindications

Carteolol is contraindicated in the following cases:

Bronchial asthma

Airway hyperreactivity

Bronchospasm

Bronchospasm

Severe chronic obstructive pulmonary disease

Severe chronic obstructive pulmonary disease

Sinus bradycardia, sick sinus syndrome

at least one of
Sinus bradycardia
Sick sinus syndrome

Sino-atrial block

Sinoatrial block

Second or third degree atrioventricular block

at least one of
Second degree atrioventricular block
Complete atrioventricular block

Cardiac failure

Cardiac failure

Cardiogenic shock

Cardiogenic shock

Get recommendations

Factors such as age, gender, and health history are evaluated to create a personalized medication regimen.

Ask the Reasoner

Related medicines

Summary of Product Characteristics (SPC) 2015: TEOPTIC Eye drops, solution
< Previous: Overview
Next: Precautions >

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.

⇈